New injection enters human testing for weight control
NCT ID NCT07224399
Summary
This early-stage study is testing a new injection called BGM1812 in healthy adults who range from normal weight to obese. Researchers want to understand how the body processes the drug, check its safety, and see if it affects body weight. The study will involve 60 participants receiving either the actual injection or a placebo (dummy treatment) without knowing which one they get.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT OR OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pharmaron CPC, Inc
RECRUITINGBaltimore, Maryland, 21201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.